News

Your Current Position: News

TongliBio reaches a strategic partnership with Occam Biolabs, Inc.

2020-05-02
TongliBio announces to complete pre-A round of financing by Tigermed investment group

2020-04-29
TongliBio announces to complete a clinical phase I trial with TL-010 in South Africa

2019-07-29
TongliBio announces to present development of TL-010 as an orphan drug at World Orphan Drug Congress

2019-04-11
TongliBio announcs to receive a clearance letter from the US FDA for its IND application of TL-010

2018-10-15
TongliBio announces TL-010 was granted with orphan drug designation by FDA

2017-07-28
TongliBio announces to receive an early investment from two private investment groups including TF capital

2017-04-05
TongliBio is invited to attend the WHO informal consultant meeting Sept.29-30. 2015 in Geneva, Switzerland

2015-09-29

Follow us:

Email：tl.office@tonglibio.com
Telephone：86-0512-58113269
Company Address：Rm 401, Bldg D, No.1 North Guotai Rd, Zhangjiagang, Suzhou, Jiangsu Province, PRC
苏ICP备13010604号

Name*

Email*

Tel*

Content

Verification code

*

Submit

COPYRIGHT (©) Tongli Biomedical Co. (TLB) Reserved

Technical support: Three to Five Interconnection

TOP